NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tom FrohlichChief Executive Officer2025-05-166,000$7.40
$44.40kBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP1,109.96%9,192,092$63.33MInstitution
Sofinnova Venture Partners X LP453.87%3,758,686$25.90MInsider
Maha Katabi453.87%3,758,686$25.90MInsider
Sofinnova Investments Inc453.87%3,758,686$25.90MInstitution
Fairmount Funds Management LLC388.87%3,220,368$22.19MInsider
Atlas Venture Fund XII LP281.10%2,327,909$16.04MInsider
Tcg Crossover Management LLC270.58%2,240,809$15.44MInstitution
Cormorant Asset Management LP245.21%2,030,691$13.99MInsider
David S. Grayzel217.26%1,799,232$12.40MInsider
Atlas Venture Life Science Advisors LLC217.26%1,799,232$12.40MInstitution

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO64.29%35.71%Net BuyingNet Buying
NLSP5.36%0.00%
ARTL9.41%90.59%
CANF0.00%0.00%
VYNE21.54%78.46%Net SellingNet Selling

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 3,827.68% institutional shareholders, 2,126.54% Jade Biosciences insiders, and 0.00% retail investors. Sofinnova Venture Partners X LP is the largest individual Jade Biosciences shareholder, owning 3.76M shares representing 453.87% of the company. Sofinnova Venture Partners X LP's Jade Biosciences shares are currently valued at $25.90M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.